USPTO 2015–2025 USPTO PatentsView US Corporation

Genomatica, Inc.

USPTO PatentsView assignee record - 155 granted patents across 29 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture).

RSS updates for this company

The verdict

According to USPTO PatentsView, Genomatica ranks #2,513 of 49,997 tracked US assignees by granted-patent volume, with 155 patents across 29 technology areas.

#2,513
of 49,997 US assignees by volume
Top 11%
by Innovation Score (51.5/100)
17.0
avg claims per patent
+20%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2513 · US Corporation #2,513 · 155 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

  • GRANTS-MID 155 grants
  • TOP-DECILE #2,513/49,997
  • PHOTO-FINISH Access Business…
  • CPC-FOCUS C12P · 29 areas
  • INNOV-PAR 51.5/100
  • CLAIMS-RICH 17.0 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-UP +20% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Access Business Group International LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Genomatica

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Genomatica's Innovation Score is 51.5/100 (top 11% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Genomatica's grants concentrate

Genomatica, Inc. is a focused PatentsView assignee: 29 CPC subclasses with 93.5% of grants classified under C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture). Peak complete grant year is 2020 (20 grants) versus a trough of 9 in 2024. By volume, Genomatica sits between Access Business Group International LLC and ONO Pharmaceutical Co., Ltd..

Genomatica's three-year grant acceleration

From 2019–2021 to 2022–2024, Genomatica, Inc. moved from 54 to 39 grants (0.72x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,078. See the growth leaderboard.

Who files at Genomatica's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Genomatica holds 155 patents at rank #2,513, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Genomatica

By rank, the assignees closest to #2,513 in granted patent volume.

Leaders in C12P (Fermentation OR Enzyme-using Processes TO Synthesise A De…)

Other assignees with the most granted patents in Genomatica's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Genomatica, neither rank-band nor same-CPC leaders (those blocks stay above).

Genomatica's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

51 Top 11% higher than 89% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

510152025 20152016201720182019202020212022202320242025 10
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Genomatica, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 15 9.7%
2016 10 6.5%
2017 10 6.5%
2018 17 11.0%
2019 14 9.0%
2020 20 12.9%
2021 20 12.9%
2022 17 11.0%
2023 13 8.4%
2024 9 5.8%
2025partial year 10 6.5%

Where it ranks

Overall rank by patents

#2,513

of 49,997 tracked assignees

Innovation Score

51.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Genomatica, Inc.'s patent record in context - here's where to go next.

  • Genomatica, Inc.'s lead technology class is C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture), 93.5% of its portfolio - see every assignee active in that class. Explore C12P
  • Ranked #2,513 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Genomatica, Inc. against Access Business Group International LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 51.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.